Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

Theriva Biologics (TOVX) announced selection as one of five finalists for Merck KGaA’s EMEA Advance Biotech Grant. Finalists for the grant will present to a six-judge panel from Merck’s ...

SANTA FE – The New Mexico Higher Education Department is granting student debt relief to more than 500 health professionals working in New Mexico as part of the agency’s Health Professional Loan ...

A key panel of U.S. health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path ...

Updates about all vaccines can be found in the Toronto Public Health (TPH) Communiqué Newsletter for Health Professionals Updates about COVID-19 vaccines for providers enrolled in the Toronto ...

Despite Merck & Co. homing in on approval for its ... Sanofi saw revenues for its consumer health arm, Opella, grow 7.9%. Earlier this week, Sanofi confirmed it had entered exclusive negotiations ...

TB disease and TB infection are both reportable diseases in Ontario. Patient consent is not required for reporting this information according to the Health Protection and Promotion Act, (HPPA). Please ...

Four such professionals slam the Republican nominee as a “malignant narcissist” incapable of caring about anyone but himself and a “danger to the republic” in a new 60-second spot. An open letter ...

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for ...

Bengaluru: Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the ...